JANESSA WATERMAN: Open Payments
NPI 1346933405 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$685 in 17 payments from 12 companies in 2025. Trend: 2023 $178 · 2024 $995 · 2025 $685
Food & beverage: $458Education: $227
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $305 |
| SEAGEN INC. | 1 | $99 |
| Incyte Corporation | 1 | $64 |
| Genentech USA, Inc. | 2 | $36 |
| Rigel Pharmaceuticals, Inc. | 1 | $32 |
| Astellas Pharma US Inc | 1 | $30 |
| ARRAY BIOPHARMA INC | 1 | $28 |
| Daiichi Sankyo Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: RYBREVANT, ERLEADA, JAKAFI, DARZALEX, TAVALISSE, Xtandi, TALVEY, XALKORI.
Industry payments across ID — which companies pay providers there.
